RISK-FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN INTRAVENOUS DRUG-USERS

被引：452
|
作者：
SCHOENBAUM, EE
HARTEL, D
SELWYN, PA
KLEIN, RS
DAVENNY, K
ROGERS, M
FEINER, C
FRIEDLAND, G
机构：
[1] MONTEFIORE MED CTR,DEPT MED,DIV INFECT DIS,BRONX,NY 10467
[2] MONTEFIORE MED CTR,DEPT BIOSTAT,BRONX,NY 10467
[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[4] CTR DIS CONTROL,CTR INFECT DIS,AIDS PROGRAM,ATLANTA,GA 30333
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 321卷 / 13期
关键词：
D O I：
10.1056/NEJM198909283211306
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：874 / 879
页数：6
相关论文
共 50 条
  • [1] A PROSPECTIVE-STUDY OF THE RISK OF TUBERCULOSIS AMONG INTRAVENOUS DRUG-USERS WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    SELWYN, PA
    HARTEL, D
    LEWIS, VA
    SCHOENBAUM, EE
    VERMUND, SH
    KLEIN, RS
    WALKER, AT
    FRIEDLAND, GH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (09): : 545 - 550
  • [2] PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION AND PREGNANCY OUTCOMES IN INTRAVENOUS DRUG-USERS
    SELWYN, PA
    SCHOENBAUM, EE
    DAVENNY, K
    ROBERTSON, VJ
    FEINGOLD, AR
    SHULMAN, JF
    MAYERS, MM
    KLEIN, RS
    FRIEDLAND, GH
    ROGERS, MF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (09): : 1289 - 1294
  • [3] RISK-FACTORS FOR HEPATITIS-C VIRUS-INFECTION AMONG INJECTING DRUG-USERS IN SYDNEY
    VANBEEK, I
    BUCKLEY, R
    STEWART, M
    MACDONALD, M
    KALDOR, J
    [J]. GENITOURINARY MEDICINE, 1994, 70 (05): : 321 - 324
  • [4] PREVALENCE, INCIDENCE, AND RISK-FACTORS OF HEPATITIS-C VIRUS-INFECTION AMONG DRUG-USERS IN AMSTERDAM
    VANDENHOEK, JAR
    VANHAASTRECHT, HJA
    GOUDSMIT, J
    DEWOLF, F
    COUTINHO, RA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04): : 823 - 826
  • [5] HEPATITIS-C VIRUS-INFECTION IN INTRAVENOUS-DRUG-USERS - PREVALENCE AND RISK-FACTORS
    GIRARDI, E
    ZACCARELLI, M
    TOSSINI, G
    PURO, V
    NARCISO, P
    VISCO, G
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1990, 22 (06) : 751 - 752
  • [6] INTRAVENOUS DRUG-USERS AND HUMAN IMMUNODEFICIENCY VIRUS TESTING AND COUNSELING
    PERRY, S
    JACOBSBERG, L
    WEILER, P
    RYAN, J
    FOGEL, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (10): : 1331 - 1332
  • [7] RECOMMENDATIONS FOR CONTROL AND PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN INTRAVENOUS DRUG-USERS
    BRICKNER, PW
    TORRES, RA
    BARNES, M
    NEWMAN, RG
    DESJARLAIS, DC
    WHALEN, DP
    ROGERS, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (10) : 833 - 837
  • [8] EPIDEMIC HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG INTRAVENOUS DRUG-USERS (IVDU)
    DAQUILA, RT
    WILLIAMS, AB
    [J]. YALE JOURNAL OF BIOLOGY AND MEDICINE, 1987, 60 (06): : 545 - 567
  • [9] PREVALENCE OF RISK-FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN THE AUSTRALIAN POPULATION
    ROSS, MW
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1988, 149 (07) : 362 - 365
  • [10] INTRAVENOUS DRUG-USERS AND HUMAN IMMUNODEFICIENCY VIRUS TESTING AND COUNSELING - REPLY
    CURTIS, JL
    CRUMMEY, FC
    BAKER, SN
    FOSTER, RE
    KHANYILE, C
    WILKINS, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (10): : 1332 - 1332
12345